AstraZeneca PLC (AZN)

Etorro trading 970x250
AstraZeneca PLC (AZN) Logo

About AstraZeneca PLC

AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. The company’s marketed products include Tagrisso, Lynparza, Imfinzi, Enhertu, Koselugo, Lumoxiti, Equidacent, Zoladex, Faslodex, Iressa, Arimidex, Casodex/Cosudex, and others for oncology diseases; Onglyza, Bydureon, Lokelma, Byetta, Qtern, Symlin, and others for cardiovascular, renal, and metabolism diseases; and Symbicort, Pulmicort, Fasenra, Daliresp/Daxas, Duaklir, Tudorza/Eklira, Bevespi, Breztri, Anifrolumab, and others for respiratory and immunology diseases. It also offers other medicines and COVID-19 products, including Synagis, Fluenz Tetra/FluMist Quadrivalent, Seroquel IR/Seroquel XR, Vimovo, Movantik/Moventig, Nexium, Losec/Prilosec, and COVID-19 Vaccine AstraZeneca. The company serves primary care and specialty care physicians through distributors and local representative offices. It has a collaboration agreement with Daiichi Sankyo to develop and commercialize DS-1062 for the treatment of trophoblast cell-surface antigen 2 (TROP2) tumor; and AliveCor, Inc. to develop non-invasive potassium monitoring solutions. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

AstraZeneca PLC News and around…

Latest news about AstraZeneca PLC (AZN) common stock and company :

The bold bet that reversed the fortunes of Oxford vaccine manufacturer
24 Oct, 2021 Yahoo! Finance

The gleaming white table in the boardroom of Oxford Biomedica’s headquarters is so enormous and heavy it can only be removed by taking down the windows and lifting it with a crane. The carpet feels soft, squishy – expensive.

Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
23 Oct, 2021 FinancialContent

AstraZeneca's therapy could have at least one major advantage.

'We're definitely not doing enough' to help global vaccinations: Former US Commerce Sec.
22 Oct, 2021 Yahoo! Finance

Former U.S. Commerce Sec. Gary Locke weighs in on the global vaccine equity debate and how the U.S. can better respond to the ongoing pandemic.

COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection
22 Oct, 2021 Yahoo! Finance

Two studies in major medical journals add to evidence that COVID-19 vaccines are safe before and during pregnancy. One study, published in The New England Journal of Medicine on Wednesday, tracked nearly 18,500 pregnant women in Norway, including about 4,500 who had miscarriages. Researchers found no link between COVID-19 vaccines and risk of first-trimester miscarriage, regardless of whether the vaccines were from Moderna, Pfizer and BioNTech, or AstraZeneca.

Pfizer says vaccine is 90.7% effective in kids aged 5 to 11: BBG
22 Oct, 2021 Yahoo! Finance

Dr. Calvin Sun, The Monsoon Diaries Founder & CEO, Clinical Assistant Professor and Attending Physician in Emergency Medicine in NYC, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.

Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
22 Oct, 2021 FinancialContent

Molnupiravir seems likely to shake up the COVID-19 antibody therapy market.

With EPS Growth And More, AstraZeneca (LON:AZN) Is Interesting
22 Oct, 2021 Yahoo! Finance

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

In-N-Out refusing to check vaccination status at some CA locations
21 Oct, 2021 Yahoo! Finance

Yahoo Finance’s Dani Romero breaks down In-N-Out Burgers’ fight over Covid-19 vaccination mandates.

December 3rd Options Now Available For AstraZeneca (AZN)
21 Oct, 2021 FinancialContent

Investors in AstraZeneca plc (AZN) saw new options become available today, for the December 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AZN options chain for the new December 3rd contracts and identified one put and one call contract of particular interest.

7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
21 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar. The post 7 Penny Stocks to Buy to Sidestep the Noise on Wall Street appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

2 COVID Stocks I'd Consider Instead of Moderna
21 Oct, 2021 FinancialContent

Moderna has likely peaked. There are much safer growth stocks to buy right now.

Wednesday Market Coverage
21 Oct, 2021 FinancialContent

Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.

Doctor on Covid-19: ‘This is a virus that is really here to stay’
20 Oct, 2021 Yahoo! Finance

Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.

AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
20 Oct, 2021 FinancialContent

AstraZeneca Plc(NASDAQ: AZN) has paused an active Phase 1 trial of AZD5991, a direct inhibitor of MCL-1, citing a potential ...

AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards
20 Oct, 2021 FinancialContent

AstraZeneca, in partnership with Scientific American Custom Media, today announced the winners of the third annual Cancer Community Awards (or C2 Awards). A part of the AstraZeneca YOUR Cancer program, the C2 Awards celebrate diverse individuals and organizations creating meaningful change in the lives of people with cancer and their loved ones across five unique categories.

Could This Beaten-Down Biotech Stock Be the Next Buyout Target?
20 Oct, 2021 FinancialContent

This gene-therapy specialist may need some help turning things around.

Novavax Shares Plunge To Lows Since Mid-May As COVID-19 Vaccine Woes Continue
20 Oct, 2021 FinancialContent

Shares ofNovavax, Inc.(NASDAQ: NVAX), which is facing an inordinate delay in getting authorization for itsCOVID-19 ...

How innovations in Covid-19 testing will play a part in this winter season
19 Oct, 2021 Yahoo! Finance

Thierry Bernard, QIAGEN CEO, joins Yahoo Finance to discuss the future of Covid-19 testing, interest and supply of at-home covid testing, and the diagnostic industry amid the pandemic.

Valneva (VALN) Reports Positive Data From COVID Vaccine Study
19 Oct, 2021 Yahoo! Finance

Valneva's (VALN) shares surge after its COVID vaccine demonstrates superiority over AstraZeneca's COVID vaccine in a phase III study.

Tuesday Talk: Gaining Again
19 Oct, 2021 FinancialContent

The market ended last week on an up note and continued to climb yesterday. It seems that September's and early October's wounds have healed. Hard to be sure, but those Israeli Ever Ready Bandage Battle Dressings are out of stock on Amazon.

The Secret To Successful Investing In Biotech
19 Oct, 2021 FinancialContent

Have you ever had a stock jump 30%, 50% or 100% in one day?

AstraZeneca, Unilever Tumble As FTSE 100 Struggles With Rising Energy Prices
19 Oct, 2021 FinancialContent

Shares of COVID-19 vaccine maker AstraZeneca PLC (NASDAQ: AZN) along with other multinationalBritish companies such ...

Chinese Growth Level
18 Oct, 2021 FinancialContent

The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues.

Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
18 Oct, 2021 FinancialContent

Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral antivirals

U.S. may soon authorize boosters for all 3 in-use vaccines, as experts renew plea for unvaccinated to get their shots
18 Oct, 2021 FinancialContent

A Food and Drug Administration advisory committee voted unanimously Friday that allowing adults who were initially vaccinated with the Johnson & Johnson one-dose vaccine against COVID-19 to get a booster is safe and effective, freeing the way for the agency to authorize its use.

These 2 Nasdaq Biotechs Are Making Huge Premarket Moves Monday
18 Oct, 2021 FinancialContent

The Nasdaq looks poised to open slightly lower after a strong week.

Why Are Valneva's Shares Trading Higher Monday Premarket?
18 Oct, 2021 FinancialContent

Valneva SE's(NASDAQ: VALN) COVID-19 vaccine elicits a robust immune response with far fewer side effects than the ...

2 Best Biotech Stocks to Buy Right Now
18 Oct, 2021 FinancialContent

These dividend stocks provide sustainable and growing dividends, which are nearly triple the S&P 500's yield.

Here’s ‘one of the most bullish signals’ ever for bitcoin that many investors may have missed
18 Oct, 2021 FinancialContent

Our call of the day from Jim Bianco sees one big reason for bitcoin's recent climb, as investors wait for news of an ETF. And here's a bullish bitcoin chart.

Pfizer and AstraZeneca vaccines were as effective as prior infection, U.K. study finds
18 Oct, 2021 Yahoo! Finance

Two doses of either the vaccine made by Pfizer and BioNTech [s:bntx] or Oxford-AstraZeneca vaccines provided a similar level of protection to prior natural infection when the Delta variant was dominant, the

AstraZeneca PLC (AZN) is a NASDAQ Common Stock listed in , ,